Teva Launches $6.75B Offering To Back Allergan, Rimsa Deals
Deal-hungry generic drugmaker Teva Pharmaceutical rolled out a $6.75 billion public offering on Monday as the Israel-based pharmaceutical giant looks to back its acquisitions of Allergan's generics unit and Mexico-based drug...To view the full article, register now.
Already a subscriber? Click here to view full article